IPHYF
Price
$2.06
Change
+$0.75 (+57.25%)
Updated
Aug 11 closing price
Capitalization
197.73M
OTLC
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
22.83M
79 days until earnings call
Interact to see
Advertisement

IPHYF vs OTLC

Header iconIPHYF vs OTLC Comparison
Open Charts IPHYF vs OTLCBanner chart's image
Innate Pharma
Price$2.06
Change+$0.75 (+57.25%)
Volume$300
Capitalization197.73M
Oncotelic Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$2.8K
Capitalization22.83M
IPHYF vs OTLC Comparison Chart in %
Loading...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHYF vs. OTLC commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHYF is a Hold and OTLC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IPHYF: $2.06 vs. OTLC: $0.05)
Brand notoriety: IPHYF and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHYF: 79% vs. OTLC: 3%
Market capitalization -- IPHYF: $197.73M vs. OTLC: $22.83M
IPHYF [@Biotechnology] is valued at $197.73M. OTLC’s [@Biotechnology] market capitalization is $22.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHYF’s FA Score shows that 0 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • IPHYF’s FA Score: 0 green, 5 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, OTLC is a better buy in the long-term than IPHYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHYF’s TA Score shows that 3 TA indicator(s) are bullish while OTLC’s TA Score has 6 bullish TA indicator(s).

  • IPHYF’s TA Score: 3 bullish, 3 bearish.
  • OTLC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OTLC is a better buy in the short-term than IPHYF.

Price Growth

IPHYF (@Biotechnology) experienced а 0.00% price change this week, while OTLC (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

OTLC is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($198M) has a higher market cap than OTLC($22.8M). OTLC YTD gains are higher at: 50.000 vs. IPHYF (-28.983).
IPHYFOTLCIPHYF / OTLC
Capitalization198M22.8M868%
EBITDAN/A-3.36M-
Gain YTD-28.98350.000-58%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A88K-
Total DebtN/A13.5M-
FUNDAMENTALS RATINGS
IPHYF vs OTLC: Fundamental Ratings
IPHYF
OTLC
OUTLOOK RATING
1..100
4157
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
3949
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OTLC's Valuation (49) in the null industry is in the same range as IPHYF (75). This means that OTLC’s stock grew similarly to IPHYF’s over the last 12 months.

OTLC's Profit vs Risk Rating (100) in the null industry is in the same range as IPHYF (100). This means that OTLC’s stock grew similarly to IPHYF’s over the last 12 months.

IPHYF's SMR Rating (95) in the null industry is in the same range as OTLC (97). This means that IPHYF’s stock grew similarly to OTLC’s over the last 12 months.

IPHYF's Price Growth Rating (39) in the null industry is in the same range as OTLC (49). This means that IPHYF’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's P/E Growth Rating (95) in the null industry is in the same range as IPHYF (100). This means that OTLC’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPHYFOTLC
RSI
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
40%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SHMDF112.25N/A
N/A
Shimano Inc.
STLY3.90N/A
N/A
HG Holdings, Inc.
KSHOF9.53N/A
N/A
K S Holdings Corporation
MTPTF1.78N/A
N/A
Motorpoint PLC
AOZOF14.02N/A
N/A
Aozora Bank Ltd.

IPHYF and

Correlation & Price change

A.I.dvisor tells us that IPHYF and KNBIF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHYF and KNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
KNBIF - IPHYF
6%
Poorly correlated
N/A
INNMF - IPHYF
6%
Poorly correlated
-3.21%
OTLC - IPHYF
4%
Poorly correlated
+10.06%
ISCO - IPHYF
1%
Poorly correlated
N/A
LIXT - IPHYF
1%
Poorly correlated
+2.24%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and TENX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and TENX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+10.06%
TENX - OTLC
23%
Poorly correlated
-0.08%
MNKD - OTLC
22%
Poorly correlated
+3.75%
IMTX - OTLC
21%
Poorly correlated
+9.44%
MMIRF - OTLC
15%
Poorly correlated
N/A
IPHYF - OTLC
4%
Poorly correlated
N/A
More